Dr. Taraneh Paravar, MD

Dr. Paravar practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Paravar's NPI, 1356640528, was assigned on March 27, 2011. Dr. Paravar graduated from David Geffen School of Medicine at UCLA in 2007. Dr. Paravar holds California license A116105.

Dr. Paravar's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Paravar's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Paravar is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Paravar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paravar practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Paravar's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Paravar is board certified in dermatology by the American Board of Dermatology. Dr. Paravar is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, itchy rashes, psoriasis and scalp rash among the conditions Dr. Paravar treats.

CMS data shows 1,611 Medicare services from Dr. Paravar across 12 procedure codes in 2024, for 423 Medicare patients. Medicare paid $78,024 for them.

CMS counts 423 Medicare patients who saw Dr. Paravar in 2024. The largest group is 65 to 74, with 176 patients. 70% of them have high cholesterol, and 61% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Paravar's median patient age at 62, with 64% women.

In 2024, Dr. Paravar wrote 1,084 Medicare Part D claims for 278 patients. 88% of them were for generic drugs. CMS names the drug for 884 of them, across 21 drugs with 11 or more claims each, at $205,116 in total drug cost. In 2023, CMS named 768 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Paravar for performance year 2024, reported as part of a group. Dr. Paravar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paravar as offering telehealth. CMS counts 394 procedures of removal of skin lesions by Dr. Paravar, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 26 papers to Dr. Paravar, published from 2009 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Chelating Agents, Dermatology and Erythema. Dr. Paravar has published most often in Dermatol Online J. Dr. Paravar's most frequent co-authors are Brian Robert Hinds, MD, Tiffany Yvonne Loh, MD and Philip R. Cohen, MD.

CMS Open Payments shows 2 general payments to Dr. Paravar from 1 drug or device company from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $250.

Dmand AI lists 2 awards for Dr. Paravar, most recently CMS Stage 1 EHR in 2013.

Dr. Paravar graduated from David Geffen School of Medicine at UCLA in 2007. Dr. Paravar is a member of AAD.

Dr. Paravar is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.